Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expressionReportar como inadecuado




Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 12:370

First Online: 27 August 2012Received: 01 February 2012Accepted: 22 August 2012DOI: 10.1186-1471-2407-12-370

Cite this article as: Liu, J., Yang, L., Zhang, J. et al. BMC Cancer 2012 12: 370. doi:10.1186-1471-2407-12-370

Abstract

BackgroundNDRG2, a member of N-Myc downstream regulated gene family, plays some roles in cellular stress, cell differentiation and tumor suppression. We have found that NDRG2 expression in cervical cancer Hela cells increases significantly upon stimulation with cisplatin, the most popular chemotherapeutic agent currently used for the treatment of advanced cervical cancer. This interesting phenomenon drove us to evaluate the role of NDRG2 in chemosensitivity of Hela cells.

MethodsIn the present study, RNA interference was employed to down-regulate NDRG2 expression in Hela cells. RT-PCR and Western blot were used to detect expression of NDRG2, Bcl-2 and Bax in cancer cells. Real-time PCR was applied to detect miR-15b and miR-16 expression levels. Drug sensitivity was determined with MTT assay. Cell cloning efficiency was evaluated by Colony-forming assay. Apoptotic cells were detected with annexin V staining and flow cytometry.

ResultsIn vitro drug sensitivity assay revealed that suppression of NDRG2 could sensitize Hela cells to cisplatin. Down-regulation of NDRG2 didn’t influence the colony-forming ability but promoted cisplatin-induced apoptosis of Hela cells. Inhibition of NDRG2 in Hela cells was accompanied by decreased Bcl-2 protein level. However, Bcl-2 mRNA level was not changed in Hela cells with down-regulation of NDRG2. Further study indicated that miR-15b and miR-16, two microRNAs targetting Bcl-2, were significantly up-regulated in NDRG2-suppressed Hela cells.

ConclusionsThese data suggested that down-regulation of NDRG2 could enhance sensitivity of Hela cells to cisplatin through inhibiting Bcl-2 protein expression, which might be mediated by up-regulating miR-15b and miR-16.

KeywordsBcl-2 Chemosensitivity Cisplatin NDRG2 RNA interference AbbreviationsHIF-1hypoxia inducible factor 1

NDRG2N-Myc downstream regulated gene 2

siRNAsmall interference RNA.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2407-12-370 contains supplementary material, which is available to authorized users.

Junye Liu, Le Yang contributed equally to this work.

Download fulltext PDF



Autor: Junye Liu - Le Yang - Jian Zhang - Jing Zhang - Yongbin Chen - Kangchu Li - Yurong Li - Yan Li - Libo Yao - Guozhen Guo

Fuente: https://link.springer.com/







Documentos relacionados